Mary joined HealthTree in 2022. She is now the AML & MDS Patient Engagement Manager. She is passionate about giving power to patients through knowledge and health education. If she can help one patient feel more confident participating in discussions with their healthcare team and making treatment decisions, she will feel like she has succeeded. When she isn't advocating for patients, she loves being an aunt, attending concerts, and experimenting with new recipes in the kitchen.

Dr. Borthakur is a Professor in the Department of Leukemia and a dedicated specialist in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). He is deeply committed to improving outcomes for patients by bringing promising new treatments and clinical trials directly into the clinic. Over the course of his career, he has led more than 30 clinical trials focused on advancing care for people living with AML and related blood cancers. His work is driven by one goal: helping patients have better, more hopeful treatment options.